Patents by Inventor Vishwas M. Paralkar

Vishwas M. Paralkar has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8017144
    Abstract: The present invention is directed to an improved system for controlled release of a bone growth promoting compound and to a flowable composition for its formation. The flowable composition is composed of a bone growth promoting compound, a thermoplastic polymer and an organic solvent. The flowable composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of a bone growth promoting compound to certain tissues.
    Type: Grant
    Filed: October 24, 2008
    Date of Patent: September 13, 2011
    Assignee: Pfizer Inc.
    Inventors: Francis Dumont, Richard L. Dunn, Scott A. Jeffers, Richard W. Korsmeyer, Mei Li, Vishwas M. Paralkar, Mingxing Zhou
  • Publication number: 20090169595
    Abstract: The present invention is directed to an improved system for controlled release of a bone growth promoting compound and to a flowable composition for its formation. The flowable composition is composed of a bone growth promoting compound, a thermoplastic polymer and an organic solvent. The flowable composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of a bone growth promoting compound to certain tissues.
    Type: Application
    Filed: October 24, 2008
    Publication date: July 2, 2009
    Inventors: Francis Dumont, Richard L. Dunn, Scott A. Jeffers, Richard W. Korsmeyer, Mei Li, Vishwas M. Paralkar, Mingxing Zhou
  • Publication number: 20040176423
    Abstract: This invention relates to pharmaceutical combinations of a prostaglandin agonist and a HMG-CoA reductase inhibitor, methods of using such combinations and kits containing such combinations. The pharmaceutical combinations, methods and kits are useful to enhance bone formation in mammals, including humans.
    Type: Application
    Filed: March 16, 2004
    Publication date: September 9, 2004
    Applicant: Pfizer Inc.
    Inventor: Vishwas M. Paralkar
  • Publication number: 20030166631
    Abstract: This invention is directed to pharmaceutical compositions and methods comprising prostglandin agonists, specifically EP2 receptor selective agonists, which are useful to enhance bone repair and healing and restore or augment bone mass in vertebrates, particularly mammals. The EP2 receptor selective agonists of the present invention are effective in the treatment of conditions such as those in which the patient has delayed or non-union fracture, bone defect, spinal fusion, bone in-growth, cranial facial reconstruction or bone sites at risk for fracture.
    Type: Application
    Filed: November 26, 2002
    Publication date: September 4, 2003
    Inventors: Francis Dumont, Jinyang Hong, Yesook Kim, Richard W. Korsmeyer, Mei Li, Vishwas M. Paralkar, David D. Thompson
  • Patent number: 6610719
    Abstract: This invention is directed to methods and compositions of treating acute or chronic renal failure or dysfunction, or conditions caused thereby, comprising administering prostaglandin agonists, which are EP4 receptor selective prostaglandin agonists.
    Type: Grant
    Filed: January 29, 2001
    Date of Patent: August 26, 2003
    Assignee: Pfizer Inc.
    Inventors: Vishwas M. Paralkar, David D. Thompson
  • Publication number: 20030104031
    Abstract: The present invention is directed to an improved system for controlled release of a bone growth promoting compound and to a flowable composition for its formation. The flowable composition is composed of a bone growth promoting compound, a thermoplastic polymer and an organic solvent. The flowable composition is capable of forming a biodegradable and/or bioerodible microporous, solid polymer matrix. The matrix is useful as an implant in patients (humans and animals) for delivery of a bone growth promoting compound to certain tissues.
    Type: Application
    Filed: November 25, 2002
    Publication date: June 5, 2003
    Inventors: Francis Dumont, Richard L. Dunn, Scott A. Jeffers, Richard W. Korsmeyer, Mei Li, Vishwas M. Paralkar, Mingxing Zhou
  • Publication number: 20020161026
    Abstract: This invention relates to pharmaceutical combinations of a prostaglandin agonist and a HMG-CoA reductase inhibitor, methods of using such combinations and kits containing such combinations. The pharmaceutical combinations, methods and kits are useful to enhance bone formation in mammals, including humans.
    Type: Application
    Filed: October 29, 2001
    Publication date: October 31, 2002
    Inventor: Vishwas M. Paralkar
  • Publication number: 20020115695
    Abstract: This invention relates to pharmaceutical combinations of a prostaglandin agonist and a HMG-CoA reductase inhibitor, methods of using such combinations and kits containing such combinations. The pharmaceutical combinations, methods and kits are useful to enhance bone formation in mammals, including humans.
    Type: Application
    Filed: October 29, 2001
    Publication date: August 22, 2002
    Inventor: Vishwas M. Paralkar
  • Publication number: 20010041729
    Abstract: This invention is directed to methods and compositions of treating acute or chronic renal failure or dysfunction, or conditions caused thereby, comprising administering prostaglandin agonists, which are EP4 receptor selective prostaglandin agonists.
    Type: Application
    Filed: January 29, 2001
    Publication date: November 15, 2001
    Inventors: Vishwas M. Paralkar, David D. Thompson